Global Coordination. Alexza agrees and acknowledges that it is in the Parties’ mutual interests to coordinate on a global basis the development, regulation, manufacturing, publication and commercialization of the Product. To facilitate such coordination, at least once each [ * ] during the Term, representatives from Teva, Alexza and Alexza’s Affiliates the Field and/or outside the U.S. shall meet to discuss matters related to the development, regulation, manufacturing, publication and commercialization of the Product on a global basis. Alexza’s licensees shall also be invited by Alexza to any such meetings in an effort to facilitate the coordination of such activities among Teva, Alexza and Alexza’s Affiliates and licensees. The location of such meetings shall rotate among locations designated by Teva and Alexza. In addition to these [ * ] meetings, Alexza shall keep Teva informed, through the JSC, as to the efforts of Alexza or its Affiliates or licensees in developing and commercializing the Product for use outside the Field and/or the U.S., and Alexza shall use reasonable efforts to share and discuss information regarding such efforts prior to Alexza or its Affiliates or licensees taking any actions related thereto. Any such disclosures shall be subject to Alexza’s obligations with its Third Party licensee(s) to maintain the confidentiality of such information, provided that any such information shall be deemed Alexza’s Confidential Information hereunder.
Appears in 2 contracts
Sources: License and Supply Agreement (Alexza Pharmaceuticals Inc.), License and Supply Agreement (Alexza Pharmaceuticals Inc.)